These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 38570140

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Der p 2.1 Peptide Abrogates House Dust Mites-Induced Asthma Features in Mice and Humanized Mice by Inhibiting DC-Mediated T Cell Polarization.
    Klein M, Colas L, Cheminant MA, Brosseau C, Sauzeau V, Magnan A, Bouchaud G.
    Front Immunol; 2020; 11():565431. PubMed ID: 33312170
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epicutaneous sensitization to house dust mite allergen requires interferon regulatory factor 4-dependent dermal dendritic cells.
    Deckers J, Sichien D, Plantinga M, Van Moorleghem J, Vanheerswynghels M, Hoste E, Malissen B, Dombrowicz D, Guilliams M, De Bosscher K, Lambrecht BN, Hammad H.
    J Allergy Clin Immunol; 2017 Nov; 140(5):1364-1377.e2. PubMed ID: 28189772
    [Abstract] [Full Text] [Related]

  • 7. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L, Petersen AH, Nawijn MC.
    Methods Mol Biol; 2021 Nov; 2223():295-335. PubMed ID: 33226602
    [Abstract] [Full Text] [Related]

  • 8. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E, Eifan AO, Baris S, Gunay E, Akturk E, Akkoc T, Bahceciler NN, Barlan IB.
    J Investig Allergol Clin Immunol; 2015 Nov; 25(5):334-42. PubMed ID: 26727762
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.
    Ohashi-Doi K, Kito H, Du W, Nakazawa H, Ipsen H, Gudmann P, Lund K.
    Int Arch Allergy Immunol; 2017 Nov; 174(1):26-34. PubMed ID: 28950271
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dectin-2 promotes house dust mite-induced T helper type 2 and type 17 cell differentiation and allergic airway inflammation in mice.
    Norimoto A, Hirose K, Iwata A, Tamachi T, Yokota M, Takahashi K, Saijo S, Iwakura Y, Nakajima H.
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):201-9. PubMed ID: 24588637
    [Abstract] [Full Text] [Related]

  • 16. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
    Boonpiyathad T, Sokolowska M, Morita H, Rückert B, Kast JI, Wawrzyniak M, Sangasapaviliya A, Pradubpongsa P, Fuengthong R, Thantiworasit P, Sirivichayakul S, Kwok WW, Ruxrungtham K, Akdis M, Akdis CA.
    Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456
    [Abstract] [Full Text] [Related]

  • 17. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB.
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.
    Canonica GW, Virchow JC, Zieglmayer P, Ljørring C, Smith IM, Mosbech H.
    Expert Rev Clin Immunol; 2016 Aug; 12(8):805-15. PubMed ID: 27322777
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cells modified with Der p1 antigen as a therapeutic potential for allergic rhinitis in a murine model via regulatory effects on IL-4, IL-10 and IL-13.
    Yu S, Jin L, Che N, Zhang R, Xu F, Han B.
    Int Immunopharmacol; 2019 May; 70():216-224. PubMed ID: 30851701
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.